ADPT: Adaptive Biotechnologies O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Kirish uchun yuqori to'siqlar va FDA ning qat'iy nazorati Adaptive Biotechnologies (ADPT) kompaniyasining bozordagi mavqeini belgilaydi. PEG asosidagi biznesning past baholanganligi omili ushbu murakkabliklarni aks ettiradi va ushbu ko'rsatkich 0.00 ga yetmoqda. Adaptive Biotechnologies (ADPT) emissiyalarni filtrlash orqali o'z laboratoriyalarining atrof-muhitga ta'sirini minimallashtiradi. Shu bilan birga, sekvenslash va maqsadli onkologiya sohasidagi faol R&D loyihalari kelajakdagi inqilobiy yangiliklar uchun yuqori salohiyatni taqdim etadi.
Adaptive Biotechnologies (ADPT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Adaptive Biotechnologies|ADPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi adaptivebiotech.com|ADPT - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Adaptive Biotechnologies Corp|ADPT - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Adaptive Biotechnologies|Shoshilinch likvidlik koeffitsiyenti adaptivebiotech.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ADPT - Sof foyda|Prognoz qilingan kelajakdagi foyda Adaptive Biotechnologies|ADPT - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Adaptive Biotechnologies Inc.|ADPT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Adaptive Biotechnologies Corp|ADPT - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Adaptive Biotechnologies|ADPT - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi adaptivebiotech.com|ADPT - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Adaptive Biotechnologies
Kompaniyaning umumiy tahlili:ADPT - Adaptive Biotech
Immun tizimi sekvensirlashida favqulodda vakolatga ega bo'lgan Adaptive Biotechnologies (ADPT) kompaniyasi foyda ko'rsatkichi va foyda o'sishi nisbati (P/E to earnings growth) yordamida baholanadi. Ushbu ko'rsatkich bozor qiymatini biznes kengayish dinamikasi bilan solishtiradi, bunda birdan past qiymat aktivning o'z salohiyatiga nisbatan past baholanganligidan dalolat beradi. Grafikdagi PEG nisbatini tahlil qilish orqali investor fundamental o'sishni spekulyativ xatarlardan samarali ajratib olishi mumkin.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Celldex Corp|Narxning foydaga va o‘sish sur’atiga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|ABCL - PEG multiplikatori|TRML: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PGEN|PHAR (Pharming Group) - PEG multiplikatori|PEG multiplikatori Nektar Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|ZBIO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Immunome, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati GOSS (gossamerbio.com)|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Septerna, Inc. SEPN|PVLA (Pieris Pharmaceuticals Inc) - Narx-foyda va o‘sish multiplikatori|SVRA (Savara Pharma) - Narxning foydaga va o‘sish sur’atiga nisbati|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda anaptysbio.com ANAB|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati kyvernatx.com KYTX|Tiziana Life Sciences Ltd (TLSA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Cabaletta Bio Inc. (CABA)|Narx-foyda va o‘sish multiplikatori VTYX|THTX (Theratechnologies, Inc) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori AVTX|ELDN - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori AGEN (Agenus Inc.)|CLYM - Narx-foyda va o‘sish multiplikatori|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATYR (aTyr Pharmaceuticals)|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti IMA|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|O‘sish sur’atiga tuzatilgan narx-foyda Equillium Bio EQ|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|Narxning foydaga va o‘sish sur’atiga nisbati IMUX (immunic-therapeutics.com)|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|InflaRx NV (IFRX) - O‘sish sur’atiga tuzatilgan narx-foyda|X4 Pharmaceuticals, Inc. - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Adicet Bio (ACET)|CELU: PEG multiplikatori|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda kezarlifesciences.com KZR|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Akari Therapeutics PLC|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA (edesabiotech.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati CARM (Carisma Therapeutics Inc.)|Narx-foyda va o‘sish multiplikatori XTLB|BOLT (Bolt Bio) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|PEG multiplikatori CALI|PEG multiplikatori affimed.com (AFMD)|Allakos - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
